[1] Mookerjee RP, Mehta G, Balasubramaniyan V, et al. Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension. J Hepatol, 2015, 62:325-331. [2] Marco VD, Calvaruso V, Ferraro D, et al. Effects of eradicating hepatitis c virus infection in patients with cirrhosis differ with stage of portal hypertension. Gastroenterology, 2016, 151:130-139. [3] Li Z. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol, 2011, 54:78-88. [4] Bissonnette J, Garcia-Pagán, Juan Carlos, Albillos, Agustín, et al. Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension. Hepatology, 2016, 64:224-231. [5] 李腾飞, 马骥, 袁慧锋,等. 高分辨C型臂CT联合去金属伪影技术在颅内动脉瘤LVIS支架辅助栓塞术中的应用. 中华神经外科杂志, 2019, 35:541-546. [6] 李晓莉, 冯卫华, 董诚, 等. CT能谱成像技术减除金属植入物伪影的定量实验研究. 中华放射学杂志, 2011, 45:736-739. [7] Ohgiya Y, Suyama J, Seino N, et al. MRI of the neck at 3 tesla using the periodically rotated overlapping parallel lines with enhanced reconstruction (propeller) (blade) sequence compared with t2-weighted fast spin-echo sequence. J Magn Reson Imaging, 2010, 32:1061-1067. [8] Afdhal N, Everson GT, Calleja JL, et al. Effect of viral suppression on hepatic venous pressure gradient in hepatitis c with cirrhosis and portal hypertension. J Viral Hepat, 2017, 24:823-831. [9] Knop V, Hoppe D, Welzel T, et al. Regression of fibrosis and portal hypertension in hcv゛ssociated cirrhosis and sustained virologic response after interferon-free antiviral therapy. J Viral Hepat, 2016, 23:994-1002. [10] Hervé G, Grabar S, Vignaux O, et al. Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2d-cine phase-contrast magnetic resonance imaging. Eur Radiol, 2016, 26:1981-1990. [11] Bayraktar Y, Oztürk MA, Egesel T, et al. Disappearance of "pseudocholangiocarcinoma sign" in a patient with portal hypertension due to complete thrombosis of left portal vein and main portal vein web after web dilatation and transjugular intrahepatic portosystemic shunt. J Clin Gastroenterol, 2000, 31:328-332. [12] Palikhe M, Xue H, Jha RK, et al. Changes in portal hemodynamics after tips in liver cirrhosis and portal hypertension. Scand J Gastroenterol, 2013, 48:570-576. [13] Zhang JS, Li L, Hou WY, et al. Spleen-preserving proximal splenic-left intrahepatic portal shunt for the treatment of extrahepatic portal hypertension in children. J Pediatr Surg, 2015, 50:1072-1075. [14] Su L, Dong J, Sun Q, et al. Spectral ct Imaging in Patients with budd-chiari syndrome: investigation of image quality. Cell Biochem Biophys, 2014, 70:1043-1049. [15] Park HS, Hwang D, Seo JK . Metal artifact reduction for polychromatic x-ray ct based on a beam-hardening corrector. IEEE Trans Med Imaging, 2016, 35:480-487. [16] Lamichhane N, Padgett K, Li X, et al. SU-F-J-73: Simple approach for quantification of metal artifact reduction capabalities of dual-energy ct. Med Phys, 2016, 43:3423-3423. [17] Mennecke A, Svergun S, Scholz B, et al. Evaluation of a metal artifact reduction algorithm applied to post-interventional flat detector ct in comparison to pre-treatment ct in patients with acute subarachnoid haemorrhage. Eur Radiol, 2017, 27:88-96. [18] 惠萍, 王新江, 崔志鹏,等. CT能谱成像在消除金属移植物伪影中的应用价值. 中华放射学杂志, 2011, 45:740-742. [19] 宁志光, 马国峰, 于远,等. 宽体探测器CT多物质伪影降低技术对CT扫描图像质量的影响. 中华放射学杂志, 2017, 51:790-793. [20] 苏蕾, 梁盼, 吕培杰,等. 宽体探测器CT多物质伪影降低技术在经颈静脉肝内门体分流术及栓塞术后门静脉血管成像中的应用价值. 中华医学杂志, 2019, 99:44-48. |